Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
There has been much speculation about the reasons behind the
substantial rise in prescribing of proton pump inhibitors; in particular, their use for minor symptoms. Bashford et al (p 452) used
the General Practitioner Research Database for the former West Midlands
region to show that, between 1991 and 1995, overall prescribing of
these drugs rose 10-fold, but unlicensed use remained high, at 46% in
1995. These changes in prescribing resulted in increases in the
proportion of new prescriptions for non-specific abdominal symptoms and
ulcer disease and a decrease for gastro-oesophageal reflux disease. The
authors also analysed prescribing analyses and cost (PACT) data and
found similar prescribing trends to those recorded with the General
Practitioner Research Database.